This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Lipoprotein (Lp)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Lipids are insoluble in water and so natural compounds such as cholesterol, phospholipids and triglyceride need to be associated with proteins, forming water soluble lipoproteins, in order to be transported around the body. These lipoprotein complexes vary with respect to size and density - the smaller the complex, the greater the density. Also, the denser the complex, the higher the proportion of cholesterol to triglyceride.

The complexes, in descending order of molecular mass, are:

  • chylomicrons
  • very low density lipoprotein (VLDL)
  • low density lipoprotein (LDL)
  • high density lipoprotein (HDL)
  • chylomicron remnants

The protein components of lipoproteins are apolipoproteins or enzymes. Apolipoproteins are structural proteins, which also may contain:

  • receptor binding sites, or
  • proteins that modify the binding of other apolipoproteins to receptors.

Lipoproteins may also contain other lipid-soluble substances e.g. lipid-soluble vitamins. These are thus able to be distributed around the body via the lipoproteins.

The major sources of lipoproteins are the gut and the liver.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.